![Jon Kayyem](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Kayyem
Directeur/Bestuurslid bij
BIODESIX, INC.
Vermogen: 110 M $ op 31-05-2026
Profiel
Jon Faiz Kayyem was the founder of GenMark Diagnostics, Inc. (1993) serving as Senior Vice President-Research & Development; Clinical Micro Sensors, Inc. (1995); Efficacy Capital Ltd. (2004) serving as Managing Partner from 2004 to 2009; and Calimmune, Inc. (2006) serving as Director from 2006 to 2017.
Current jobs include Independent Director at Biodesix, Inc. since 2021, Independent Director at Inhibrx Biosciences, Inc. since 2024, and Trustee at California Institute of Technology since 2006.
Former jobs include Chief Executive Officer at Osmetech Ltd. from 2009 to 2010, Independent Director at Sanofi AATD, Inc. from 2018 to 2024, and Vice President-Life Sciences at Motorola, Inc. from 2000 to 2004.
Education includes undergraduate and graduate degrees from Yale University in 1984 and 1985, respectively, and a doctorate from California Institute of Technology in 1991.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
7,22% | 03-06-2026 | 1.059.046 ( 7,22% ) | 110 M $ | 31-05-2026 |
BIODESIX, INC. 0,22% | 04-03-2026 | 17.876 ( 0,22% ) | 291 736 $ | 31-05-2026 |
Actieve functies van Jon Kayyem
| Bedrijven | Functie | Begin |
|---|---|---|
| BIODESIX, INC. | Directeur/Bestuurslid | 06-12-2021 |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | 30-09-2011 |
Eerdere bekende functies van Jon Kayyem
| Bedrijven | Functie | Einde |
|---|---|---|
| INHIBRX, INC. | Directeur/Bestuurslid | 30-05-2024 |
| GENMARK DIAGNOSTICS, INC. | Algemeen Directeur | 01-02-2018 |
Calimmune, Inc.
 Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Oprichter | 01-01-2017 |
Osmetech Ltd.
 Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Algemeen Directeur | 01-05-2010 |
Efficacy Capital Ltd. | Oprichter | 01-09-2009 |
Opleiding van Jon Kayyem
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
91
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Motorola, Inc.
 Motorola, Inc. Telecommunications EquipmentElectronic Technology Develops communication and electronic solutions | Electronic Technology |
Efficacy Capital Ltd. | |
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes immunoassays, serology, molecular & tissue diagnostic testing systems | Health Technology |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Design, development, manufacture and sale of molecular diagnostics instruments and consumables enabling | Health Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Micro Sensors, Inc.
 Clinical Micro Sensors, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures instruments used in genetic diagnostics testing | Electronic Technology |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
